We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Automatic Zone Analysis System

By Biotechdaily staff writers
Posted on 27 Feb 2006
An automatic zone analyzer produces accurate plate readings in seconds, saving antibiotic and vaccine manufacturers both time and money. More...


Counting colonies and measuring zones using traditional manual methods are tedious tasks requiring high levels of concentration. The new colony counters and zone sizers improve a laboratory's efficiency, reliability, and productivity.

Autozone was developed by Synbiosis (Cambridge, UK). The analyzer consists of a computer-controlled, high-resolution charged-couple device (CCD) camera on an automated gantry system. The camera automatically moves from zone to zone, rapidly reading and recording zone diameters with +/-0.01mm accuracy. The system can analyze a 64-zone bioassay plate (including the diameter calculation and image archiving), in just 70 seconds, around 25 times faster than manual analysis. Additionally, the average diameter measurement is based on the entire zone area, making the results more precise than those taken from manual single or double diameter measurements.

Users can create and recall automatic scanning patterns for different plate configurations, making Autozone ideal for multi-zone bioassay plate analysis (commonly 36 and 64 zone plates), and single radial immunodiffusion assay plate reads, according to Synbiosis. The zone reading results and zone images are automatically recorded by good laboratory practice (GLP) compliant software, eliminating any keying or scanning errors that can occur during data transfer. This information is instantly saved to hard disk for secure archiving or to generate professional reports for audit by regulatory agencies.

Simon Johns, divisional manager for Synbiosis, stated: "We are very excited about our new Autozone system because it makes an essential part of antibiotic or vaccine manufacturing an effortless task. As the system can analyze 25 bioassay plates and produce results of unrivalled accuracy in the time it takes a scientist to manually measure just one, we are confident that any antibiotic or vaccine manufacturer using Autozone will significantly increase their productivity.”



Related Links:
Synbiosis

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Blood Test Measuring Tumor Proliferation May Guide Treatment Sequencing in Metastatic Melanoma

Metastatic melanoma remains difficult to manage because outcomes vary widely and early prognostic markers are limited. About half of patients carry a BRAF gene mutation, giving clinicians several first-line... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Comprehensive Genomic Testing Expands Treatment Options for Advanced Cancers

Selecting effective therapies for advanced cancers remains difficult because standard tumor testing often targets only a limited set of genes. As options dwindle, many patients face decisions without strong... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.